(Alliance News) - AstraZeneca PLC on Monday reported positive study results for two separate treatments for prevention of cardiovascular events, particularly heart attacks in patients with or of Read More
(Alliance News) - Stocks in London were set for to open slightly higher Monday, after a slew of tariffs imposed by the US government on Chinese goods came into effect on Sunday but no new blow-ups Read More
(Alliance News) - Workers from some of the UK's biggest manufacturers have warned the Government that a no-deal Brexit would lead to a collapse in investment and could spark factory delegation Read More
(Alliance News) - AstraZeneca PLC on Thursday said its phase 3 Tulip 2 trial of potential new lupus drug anifrolumab met its primary endpoint.The trial assessed anifrolumab as a treatment 2 Read More
(Alliance News) - Stocks in London are set to open slightly lower on Thursday, easing after the boost given to the previous session by a weaker pound amid political crisis in the UK.In UK - Read More
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------BP, up Read More
(Alliance News) - AstraZeneca PLC on Wednesday posted positive results from its phase three trial of Breztri Aerosphere and said Fasenra has been granted orphan drug designation in the phase 3 of Read More
(Alliance News) - AstraZeneca PLC on Tuesday said the US has granted fast track designation for the development of Farixga as a treatment for renal failure in chronic kidney disease.The US Read More
(Alliance News) - AstraZeneca PLC announced Chinese approval for roxadustat in non-dialysis-dependent patients on Thursday, as well as the USD95 million purchase of a priority review voucher in Co Read More
(Alliance News) - UK Prime Minister Boris Johnson on Thursday is set for showdown Brexit talks in Paris, hours after French President Emmanuel Macron ruled out making concessions.The UK was Read More
(Alliance News) - Stocks in London are set to open lower on Thursday after minutes from the US Federal Reserve were less dovish than markets had been anticipating.In early UK company news, Read More
(Alliance News) - AstraZeneca PLC on Wednesday said its phase 3 Neptune trial of Imfinzi in combination with tremelimumab did not meet its primary endpoint of improving overall was a randomised, a Read More
(Alliance News) - Stocks in London are set to open on a cautious note on Wednesday ahead of the US Federal Reserve releasing minutes from its latest monetary policy meeting.In early UK company a a Read More
(Alliance News) - London stocks were building on recent gains on Tuesday as the previous session's optimism over US-China trade talks and German economic stimulus flowed into a second day. the Read More
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------J up 2.5%, Group, Read More
(Alliance News) - Stock prices in London opened higher on Tuesday continuing positive momentum from Monday, amid optimism over US-China trade negotiations after the US granted telecom equipment a Read More
(Alliance News) - FTSE 100-listed AstraZeneca PLC on Tuesday reported positive results from the third phase of DAPA-HF trial.The drugmaker said the study showed Farxiga met the primary with Read More
(Alliance News) - AstraZeneca PLC on Monday said it appointed Michel Demare as a non-executive director and a member of the audit committee, with effect from September 1.The drugmaker said Read More
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:----------FTSE 100----------MORGAN STANLEY RAISES TO Read More
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - Group, up 5.0%. The insurer reported profit in of Read More